Home/Filings/4/0001209191-18-034866
4//SEC Filing

ANNETT WILLIAM 4

Accession 0001209191-18-034866

CIK 0001642380other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 7:41 PM ET

Size

11.2 KB

Accession

0001209191-18-034866

Insider Transaction Report

Form 4
Period: 2018-05-23
ANNETT WILLIAM
DirectorPresident and CEO
Transactions
  • Award

    Option to Purchase Common Stock

    2018-05-23+180,000180,000 total
    Exercise: $2.35Exp: 2028-05-22Common Stock (180,000 underlying)
Holdings
  • Option to Purchase Common Stock

    Exercise: $2.20Exp: 2025-01-08Common Stock (5,000 underlying)
    5,000
  • Option to Purchase Common Stock

    Exercise: $4.70Exp: 2027-02-16Common Stock (225,000 underlying)
    250,000
  • Option to Purchase Common Stock

    Exercise: $3.06Exp: 2026-02-15Common Stock (250,000 underlying)
    250,000
  • Option to Purchase Common Stock

    Exercise: $2.20Exp: 2025-06-15Common Stock (605,000 underlying)
    605,000
Footnotes (5)
  • [F1]One quarter of the options shall vest upon completion of the clinical utility study for OncoCyte's DetermaVu product candidate and OncoCyte has received a publication date for a full article describing those results, and the balance shall vest upon obtaining a Medicare local coverage determination for OncoCyte's DetermaVu product candidate.
  • [F2]One quarter of the options vested on February 16, 2018, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment.
  • [F3]One quarter of the options vested on February 15, 2017, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment.
  • [F4]One quarter of the options vested on June 15, 2016, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment.
  • [F5]Became exercisable in two equal installments based upon continued service on the board of directors from the date of grant on January 9, 2015.

Issuer

OncoCyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001662553

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 7:41 PM ET
Size
11.2 KB